| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |